Promethazine hydrochloride therapy in severely Rh-sensitized pregnancies

Area of Science:

• Obstetrics and Gynecology
• Immunology
• Pharmacology

Background:

• Rh sensitization is a serious condition during pregnancy.
• Prompt treatment is crucial for fetal survival and health.

Purpose of the Study:

• To evaluate the efficacy of promethazine hydrochloride in managing Rh-sensitized pregnancies.
• To assess the impact of promethazine on fetal outcomes in Rh-sensitized pregnancies.

Main Methods:

• A cohort of 17 severely Rh-sensitized women underwent treatment with promethazine hydrochloride during 18 pregnancies.
• Treatment followed a protocol established by Gusdon et al.

Main Results:

• An amelioration of Rh disease was observed in 10 of the 18 pregnancies.
• Infant survival was achieved in 9 of these 10 pregnancies.
• In 4 cases, promethazine was unnecessary as infants were Rh-negative; outcomes in 2 pregnancies were uncertain but resulted in live births.

Conclusions:

• Promethazine hydrochloride demonstrates an ameliorating effect on Rh-sensitized pregnancies.
• The findings support previous research suggesting promethazine's therapeutic value in managing Rh incompatibility.
• Further investigation may be warranted to fully elucidate the mechanism and optimal use of promethazine in Rh disease.